See other companies on Welcome to the Jungle
Psyomics
Precision Mental health Platform
- 1-20 employees
- Healthcare
- B2B
- Mental health
- MedTech
- London, UK
Jump to section
Company mission
To optimise and accelerate mental health access and outcomes for people, providers and populations.
Most candidates hear
back within 2 weeks
40% female employees
Our take
With the rise in mental health awareness, healthcare institutions such as the NHS are under increasing pressure to provide the mental healthcare people need and deserve. Psyomics, a health-tech company based in Cambridge, is developing products and services to support healthcare professionals with more efficient treatment and care pathway planning.
The company's digital assessment platform, Censeo, streamlines mental health assessments whilst facilitating the closer investigation of particular concerns, patient history, and symptoms - allowing clinicians to make more informed decisions. By enabling the deeper understanding of mental health on an individual level, Psyomics supplies the means to tailor treatment approaches, fighting the one-size-fits-all mentality which has classically underpinned this healthcare.
The platform has been developed by psychiatrists and psychologists, ensuring it is clinically-led and research-first, and it has received positive feedback from both GPs and patients. With strong funding secured, Psyomics is looking to expand its reach, grow its team, and expand further across the NHS as it showcases how its technology can have a positive affect for mental health patients across the board.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Excellent pension provision
- Private healthcare
- Flexible working hours and hybrid working options
- 30 days' annual leave PLUS bank holidays
- Personal development opportunities
- Generous parental leave provisions
Company values
- Clinically led - Clinical excellence is our priority. We utilise our extensive clinical expertise to deliver trusted, clinically validated digital solutions for the mental healthcare market
- Quality focused - Quality underpins everything we do. We are dedicated to delivering outstanding products that not only comply with regulatory and quality standards but exceed them
- Collaborative - We work together to achieve our goals and make sure every voice is heard. We listen to customers and take advice from service user groups at every stage of product development
- Research driven - Our business is built on research. We are committed to taking an evidence-based approach in everything we do
- Dedicated - We are a dedicated team and encourage individual initiative. We take ownership of our work and opportunities to make an impact
- Innovative - We support and encourage creative thinking. We are constantly reviewing and striving to develop the most innovative products based on the latest scientific understanding and best clinical practice
Funding (last 2 of 7 rounds)
Jun 2024
$5.1m
EARLY VC
Jun 2022
$3.1m
EARLY VC
Total funding: $14.4m
Leadership
Sabine Bahn
(Co-Founder & Chief Medical Officer)A practicing psychiatrist, Professor of Neurotechnology, and head of the Cambridge Centre for Neuropsychiatric Research.
Dr Melinda Rees
(Chief Executive Officer, Non-founder)20-year senior-level career as a pioneering clinical & strategic leader in the NHS and private sectors Commercial international healthcare experience (US, Europe)